Skip to search formSkip to main contentSkip to account menu

NovoLog

Known as: NovoRapid 
National Institutes of Health

Related topics

Related topics

3 relations
3 ML Insulin, Aspart, Human 100 UNT/ML Pen Injector [NovoLog]

Broader (2)

Insulin AspartInsulin, Aspart, Human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
In vitro assessment of the influence of intravenous extension set materials on insulin aspart drug delivery
Insulin is a frequently prescribed drug in hospitals and is usually administered by syringe pumps with an extension line which… 
2018
2018
BENEFITS OF EARLY SCREENING AND PROPER TREATMENT IN PATIENT WITH SIGNIFICANT RISK FACTORS FOR GESTATIONAL DIABETES MELLITUS (CASE REPORT).
Gestational diabetes mellitus (GDM) occurs in 2-9% of all pregnancies. Evidence suggests that the use of insulin in treating… 
2017
2017
Fiasp: a new faster‐acting insulin aspart formulation for diabetes
Fiasp is a new faster‐acting formulation of insulin aspart that is absorbed more quickly than conventional insulin aspart… 
2010
2010
Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
Objective: To compare the treatment costs of insulin glargine (IG; Lantus®) to detemir (ID; Levemir®), both combined with bolus… 
2009
2009
Influence of polymers ratio on insulin-loaded nanoparticles based on poly-ε-caprolactone and Eudragit® RS for oral administration
Nanoparticles loaded with two different commercial insulins (Actrapid®, Novorapid®) and based on different blends of a… 
2009
2009
Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens
Abstract Objective: This study compared injection force (measured by glide force [GF] and glide force variability [GFV]) and… 
2007
2007
A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes
Aim:  To evaluate the pharmacokinetic and pharmacodynamic properties of insulin aspart in elderly patients with diabetes. 
2005
2005
Efficacy of Pitavastatin , a New HMG-CoA Reductase Inhibitor , on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes
A llergy to insulin has become rare with human recombinant insulin or its analogs, with an estimated incidence of 1%. The most… 
2004
2004
Insulin for toddlers with difficult diabetes.
Effective control of blood glucose in toddlers with diabetes can be difficult for a variety of reasons. Unpredictable eating… 
2001
2001
The insulin analog aspart: a safe alternative in insulin allergy.
The introduction of human recombinant insulin has considerably lowered, but not eliminated, adverse reactions to insulin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)